Global Hydrate Inhibitors Market is estimated to be valued at US$ 211.68 Mn in 2021, according to the Global Hydrate Inhibitors Market Report, by Inhibitor Type (Thermodynamic Inhibitors, Low Dosage Hydrate Inhibitors (LDHI’s), and Hybrid) and by Region (North America, Europe, Asia-pacific, Latin America, and Middle East & Africa), published by Coherent Market Insights.
Global hydrate inhibitors market was valued at US$ 211.68 Mn in 2021. The hydrate inhibitors market is expected to exhibit a CAGR of 6.26 % over the forecast period (2022-2030), to reach US$ 364.36 Mn by 2030.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/hydrate-inhibitors-market-555
Key Trends and Analysis of the Global Hydrate Inhibitors Market:
Low dosage hydrate inhibitors (LDHI) segment held a significant market share in 2021 in the global hydrate inhibitors market due to key players focusing on new product launches and development of novel technology in this segment. For instance, in September 2020, Nalco, a subsidiary of Ecolab Inc., expanded its portfolio of low-dosage hydrate inhibitors for use in the Gulf of Mexico. The new line of products with anti-agglomerant technology allows to simplify logistics, reduces safety risk, and increases production, while sustaining assets and lowering the total cost of operation.